Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6414 USD | -3.62% | -7.86% | -13.98% |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Apr. 04 | Traws Pharma, Inc. Announces Chief Executive Office Changes | CI |
Financials (USD)
Sales 2024 * | 210K | Sales 2025 * | 300K | Capitalization | 13.52M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -28M | EV / Sales 2024 * | 64.4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 45.1 x |
P/E ratio 2024 * |
-0.74
x | P/E ratio 2025 * |
-0.77
x | Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.1% |
Latest transcript on Traws Pharma, Inc.
1 day | -3.62% | ||
1 week | -7.86% | ||
Current month | -36.50% | ||
1 month | -26.10% | ||
3 months | -7.86% | ||
6 months | -3.16% | ||
Current year | -13.98% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Fruchtman
PSD | President | 73 | 15-01-18 |
Mark Guerin
DFI | Director of Finance/CFO | 55 | 13-08-31 |
Meena Arora
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Marino
BRD | Director/Board Member | 74 | 15-06-30 |
Jack Stover
BRD | Director/Board Member | 69 | 16-05-22 |
Mary Shoemaker
BRD | Director/Board Member | 63 | 20-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.6414 | -3.62% | 39,713 |
24-04-23 | 0.6655 | -0.82% | 55,839 |
24-04-22 | 0.671 | +0.15% | 44,722 |
24-04-19 | 0.67 | -3.69% | 30,690 |
24-04-18 | 0.6957 | +1.90% | 34,280 |
Delayed Quote Nasdaq, April 24, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.98% | 14.03M | |
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- TRAW Stock